James G. Coulter, 10% Owner at Trevi Therapeutics, Inc. (TRVI), sold 600 shares at $2.70 ($2K) on 2022-05-02, disclosed to the SEC on 2022-05-04.
Open-market sale of $2k TRVI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| PrivateTPG Twin Brook Capital Income Fund | BUY | 2025-12-30 | $100.0M | — | Filing → |
| SION | BUY |
| 2025-07-01 |
| $950K |
| — |
| Filing → |
| TPG | SELL | 2024-02-29 | $109.7M | — | Filing → |
| SLGG | SELL | 2023-08-17 | $3.4M | — | Filing → |
| SLGG | SELL | 2023-07-28 | $38K | — | Filing → |